TY - JOUR
T1 - Red blood cell precursor mass as an independent determinant of serum erythropoietin level
AU - Cazzola, Mario
AU - Guarnone, Roberta
AU - Cerani, Paola
AU - Centenara, Esther
AU - Rovati, Andrea
AU - Beguin, Yves
PY - 1998/3/15
Y1 - 1998/3/15
N2 - Serum erythropoietin (sEpo) concentration is primarily related to the rate of renal production and, under the stimulus of hypoxia, increases exponentially as hemoglobin (Hb) decreases. Additional factors, however, appear to influence sEpo, and in this work, we performed studies to evaluate the role of the red blood cell precursor mass. We first compared the relationship of sEpo with Hb in patients with low versus high erythroid activity. The first group included 27 patients with erythroid aplasia or hypoplasia having serum transferrin receptor (sTfR) levels <3 mg/L (erythroid activity <0.6 times normal), while the second one included 28 patients with β-thalassemia intermedia having sTfR levels > 10 mg/L (erythroid activity > 2 times normal). There was no difference between the two groups with respect to Hb (8.3 ± 1.6 v 8.0 ± 1.3 g/dL, P > .05), but sEpo levels were notably higher in patients with low erythroid activity (1,601 ± 1,542 v 235 ± 143 mU/mL, P <.001). In fact, multivariate analysis of variance (ANOVA) showed that, at any given Hb level, sEpo was higher in patients with low erythroid activity (P
AB - Serum erythropoietin (sEpo) concentration is primarily related to the rate of renal production and, under the stimulus of hypoxia, increases exponentially as hemoglobin (Hb) decreases. Additional factors, however, appear to influence sEpo, and in this work, we performed studies to evaluate the role of the red blood cell precursor mass. We first compared the relationship of sEpo with Hb in patients with low versus high erythroid activity. The first group included 27 patients with erythroid aplasia or hypoplasia having serum transferrin receptor (sTfR) levels <3 mg/L (erythroid activity <0.6 times normal), while the second one included 28 patients with β-thalassemia intermedia having sTfR levels > 10 mg/L (erythroid activity > 2 times normal). There was no difference between the two groups with respect to Hb (8.3 ± 1.6 v 8.0 ± 1.3 g/dL, P > .05), but sEpo levels were notably higher in patients with low erythroid activity (1,601 ± 1,542 v 235 ± 143 mU/mL, P <.001). In fact, multivariate analysis of variance (ANOVA) showed that, at any given Hb level, sEpo was higher in patients with low erythroid activity (P
UR - http://www.scopus.com/inward/record.url?scp=0032520980&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032520980&partnerID=8YFLogxK
M3 - Article
C2 - 9490701
AN - SCOPUS:0032520980
VL - 91
SP - 2139
EP - 2145
JO - Blood
JF - Blood
SN - 0006-4971
IS - 6
ER -